Business · 09/09/2016Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Blood Products Advisory Committee
Summary
The FDA is hosting a public meeting of the Blood Products Advisory Committee to provide advice on regulatory issues, following a request from the committee to discuss recent developments in the field of blood products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →